Cargando…
Low interferon-gamma release in response to phytohemagglutinin predicts the high severity of diseases
A clinically useful immune biomarker could potentially assist clinicians in their decision making. We stimulated T-cell proliferation to secret interferon gamma (IFN-γ) by phytohemagglutinin, and then measured the production of IFN-γ (mitogen value [M value]). We aimed to determine the relationship...
Autores principales: | He, Xing, Liu, Li-Ying, Ji, Xiao-Kun, Xian, Ya-Bin, Yan, Yong-Jun, Xu, Hui-Juan, Sha, Li, Pu, Chun-Li, Zhou, Jun-Yan, Yuan, Chun-Yan, Yang, Mei, Zheng, Song-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709005/ https://www.ncbi.nlm.nih.gov/pubmed/31145331 http://dx.doi.org/10.1097/MD.0000000000015843 |
Ejemplares similares
-
Neutrophil-to-Lymphocyte Ratio Is Associated with Impaired Interferon-Gamma Release to Phytohemagglutinin
por: Woo, Kwang-Sook, et al.
Publicado: (2015) -
Phytohemagglutinin ameliorates HFD-induced obesity by increasing energy expenditure
por: Zhang, Yunxia, et al.
Publicado: (2021) -
Accuracy of the interferon-gamma release assay for the diagnosis of tuberculous pleurisy: an updated meta-analysis
por: Pang, Cai-Shuang, et al.
Publicado: (2015) -
Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016) -
T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer
por: Kamimaki, Chisato, et al.
Publicado: (2021)